SCHEMBL7473442

SCHEMBL7473442

CCC(=O)Oc1c(N)cccc1CO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.42
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
ESR1 P03372 2/20 0.38
HIF1A Q16665 2/20 0.38
ELANE P08246 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CHEK1 O14757 1/20 0.35
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CDC25B P30305 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7390463 0.90 ACHE (0.44) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL5285423 0.86 ACHE (0.49) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL7389208 0.82 SMN1; SMN2 (0.47) ACHEHIF1AELANESMN1; SMN2ALDH1A1
SCHEMBL7390544 0.80 SMN1; SMN2 (0.50) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL2671806 0.80 ACHE (0.47) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL7389800 0.79 ACHE (0.43) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL7390728 0.79 ACHE (0.43) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL28832125 0.79 ACHE (0.43) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL7387661 0.79 ACHE (0.43) ACHEESR1HIF1AELANESMN1; SMN2
SCHEMBL2469340 0.79 ACHE (0.43) ACHEESR1HIF1AELANESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
EP-1252178-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-10-30 EP disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed